东曜药业-B:董事会将于8月21日审议2026年中期业绩

公告速递
Jul 10

东曜药业股份有限公司(01875,东曜药业-B)7月10日在港交所公告称,公司董事会已定于2026年8月21日(星期五)召开会议,届时将审议并批准本集团截至2026年6月30日止六个月的中期业绩,并处理其他事项。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10